The Diabetes Genome Anatomy Project (DGAP) represents a new initiative in unraveling the interface between insulin action; insulin resistance and the genetics of type II diabetes. The project was developed in conjunction with NIDDK and in response to the report of the Diabetes Research Working Group, and is presented in the form of a Bioengineering, Bioimaging, and Bioinformatics Research Partnership (BRP), representing the efforts of investigators from five institutions. There are six projects and four cores that form a highly interactive matrix and also serve as a scaffold on which to build future projects or interactions with related projects and grants. The overall goal of the project is to identify the sets of the genes and gene products involved in insulin action and the predisposition to type 2 diabetes, as well as the secondary changes in gene expression that occur in response to the metabolic abnormalities present in diabetes. There are five major and one pilot project involving human and rodent tissues that will allow us to: (1) Create a database of the genes expressed in insulin-responsive tissues, as well as accessible tissues such as lymphocytes, that are regulated by insulin, insulin resistance and diabetes. (2) Assess levels and patterns of gene expression in each tissue before and after insulin stimulation in normal and genetically-modified rodents; normal, insulin resistant and diabetic humans, and in cultured and freshly isolated cell models. (3) Correlate the level and patterns of expression at the mRNA and/or protein level with the genetic and metabolic phenotype of the animal or cell. (4) Generate genomic sequence from a panel of humans with type 2 diabetes focusing on the genes most highly regulated by insulin and diabetes to determine the range of sequence and expression variation in these genes and the proteins they encode, which might affect the risk of diabetes or insulin resistance. The resultant information will be used to create a highly annotated and interactive public database, standardized protocols for gene expression and proteomic analysis, and ultimately diabetes-specific and insulin action-specific DNA chips for investigators in the field. In this manner, we propose to define the normal anatomy of gene expression (i.e. basal levels of expression and response to insulin), the morbid anatomy of gene expression (i.e., the impact of diabetes on expression patters and the insulin response) and the extent to which genetic variability might contribute to the alterations in expression or to diabetes itself. This will aid all investigators in the quest to unravel the complexity of insulin action and its alterations in diabetes, and ultimately help develop more effective and specific modes for classification, metabolic staging and therapy of the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK060837-02
Application #
6668611
Study Section
Special Emphasis Panel (ZRG1-SSS-3 (02))
Program Officer
Smith, Philip F
Project Start
2002-09-30
Project End
2007-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
2
Fiscal Year
2003
Total Cost
$2,000,001
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Vienberg, Sara Gry; Kleinridders, André; Suzuki, Ryo et al. (2015) Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity. Mol Metab 4:144-50
Wewalka, Marlene; Patti, Mary-Elizabeth; Barbato, Corinne et al. (2014) Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin. J Clin Endocrinol Metab 99:1442-51
Lee, Kevin Y; Yamamoto, Yuji; Boucher, Jeremie et al. (2013) Shox2 is a molecular determinant of depot-specific adipocyte function. Proc Natl Acad Sci U S A 110:11409-14
Lee, Kevin Y; Russell, Steven J; Ussar, Siegfried et al. (2013) Lessons on conditional gene targeting in mouse adipose tissue. Diabetes 62:864-74
Navaroli, Deanna M; Bellve, Karl D; Standley, Clive et al. (2012) Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis. Proc Natl Acad Sci U S A 109:E471-80
Monetti, Mara; Nagaraj, Nagarjuna; Sharma, Kirti et al. (2011) Large-scale phosphosite quantification in tissues by a spike-in SILAC method. Nat Methods 8:655-8
Walther, Dirk M; Mann, Matthias (2011) Accurate quantification of more than 4000 mouse tissue proteins reveals minimal proteome changes during aging. Mol Cell Proteomics 10:M110.004523
Goldfine, Allison B; Gerwien, Robert W; Kolberg, Janice A et al. (2011) Biomarkers in fasting serum to estimate glucose tolerance, insulin sensitivity, and insulin secretion. Clin Chem 57:326-37
Burkart, Alison; Shi, Xiarong; Chouinard, My et al. (2011) Adenylate kinase 2 links mitochondrial energy metabolism to the induction of the unfolded protein response. J Biol Chem 286:4081-9
Pihlajamäki, Jussi; Lerin, Carles; Itkonen, Paula et al. (2011) Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis. Cell Metab 14:208-18

Showing the most recent 10 out of 90 publications